Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 9/2013

Content (9 Articles)

Original Article

Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue

Anna M. Sherwood, Ryan O. Emerson, Dominique Scherer, Nina Habermann, Katharina Buck, Jürgen Staffa, Cindy Desmarais, Niels Halama, Dirk Jaeger, Peter Schirmacher, Esther Herpel, Matthias Kloor, Alexis Ulrich, Martin Schneider, Cornelia M. Ulrich, Harlan Robins

Original Article

Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion

Sara Fritzell, Emma Sandén, Sofia Eberstål, Edward Visse, Anna Darabi, Peter Siesjö

Original Article

CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis

Bridget Charbonneau, Alice H. Wang, Matthew J. Maurer, Yan W. Asmann, Clive S. Zent, Brian K. Link, Stephen M. Ansell, George J. Weiner, Nazan Ozsan, Andrew L. Feldman, Thomas E. Witzig, Julie M. Cunningham, Ahmet Dogan, Thomas M. Habermann, Susan L. Slager, Anne J. Novak, James R. Cerhan

Original Article

Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer

Anneke Neumann, Helen Hörzer, Nina Hillen, Karin Klingel, Barbara Schmid-Horch, Hans-Jörg Bühring, Hans-Georg Rammensee, Hermann Aebert, Stefan Stevanović

Open Access Original Article

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma

Einar Osland Vik-Mo, Marta Nyakas, Birthe Viftrup Mikkelsen, Morten Carstens Moe, Paulina Due-Tønnesen, Else Marit Inderberg Suso, Stein Sæbøe-Larssen, Cecilie Sandberg, Jan E. Brinchmann, Eirik Helseth, Anne-Marie Rasmussen, Knut Lote, Steinar Aamdal, Gustav Gaudernack, Gunnar Kvalheim, Iver A. Langmoen

Original Article

Vaccination of castration-resistant prostate cancer patients with TroVax (MVA–5T4) in combination with docetaxel: a randomized phase II trial

Richard Harrop, Franklin Chu, Nashat Gabrail, Sandy Srinivas, Daniel Blount, Anna Ferrari

Original Article

Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer

James L. Gulley, Christopher R. Heery, Ravi A. Madan, Beatriz A. Walter, Maria J. Merino, William L. Dahut, Kwong-Yok Tsang, Jeffrey Schlom, Peter A. Pinto

Open Access Original Article

Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models

Maria Jure-Kunkel, Gregg Masters, Emel Girit, Gennaro Dito, Francis Lee, John T. Hunt, Rachel Humphrey

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine